Baillie Gifford - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 162 filers reported holding FIBROGEN INC in Q1 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of FIBROGEN INC
ValueSharesWeighting
Q1 2023$10,058
+34.4%
539
+15.4%
0.00%
Q4 2022$7,481
+24.7%
4670.0%0.00%
Q3 2022$6,000
+20.0%
4670.0%0.00%
Q2 2022$5,000
-16.7%
4670.0%0.00%
Q1 2022$6,000
-14.3%
4670.0%0.00%
Q4 2021$7,000
+40.0%
4670.0%0.00%
Q3 2021$5,000
-58.3%
4670.0%0.00%
Q2 2021$12,000
-7.7%
467
+23.9%
0.00%
Q1 2021$13,0000.0%377
+8.6%
0.00%
Q4 2020$13,0003470.00%
Other shareholders
FIBROGEN INC shareholders Q1 2022
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 305,784$8,143,0008.63%
Vantage Consulting Group Inc 605,713$16,130,0002.81%
GREAT POINT PARTNERS LLC 500,000$13,315,0002.79%
HHLR ADVISORS, LTD. 3,955,787$105,343,0001.08%
Intercontinental Wealth Advisors, LLC 191,300$5,094,0001.01%
Ikarian Capital, LLC 250,000$6,657,0000.54%
BHK Investment Advisors, LLC 45,100$1,201,0000.49%
Ikarian Capital, LLC 193,800$5,161,0000.42%
Omega Fund Management, LLC 130,646$3,479,0000.39%
Rhenman & Partners Asset Management AB 200,000$5,326,0000.36%
View complete list of FIBROGEN INC shareholders